ATF2 and arthritic joint disease: In terms of anti-arthritis, ginsenoside Rc (40 μg/mL and 60 μg/mL) exhibits significant activity, which can alleviate inflammation by inhibiting the targeted binding kinase 1/interfering regulatory factor-3 and p38/activating transcription factor-2 pathways [13].